Current Statins News and Events | Page 24

Current Statins News and Events, Statins News Articles.
Sort By: Most Relevant | Most Viewed
Page 24 of 25 | 1000 Results
New study links common cholesterol-lowering drugs to reduced prostate cancer risk
Men who take even small amounts of common cholesterol-lowering drugs such as Lovastatin and Simvastatin have a significantly reduced risk of prostate cancer, according to a new study by Oregon Health & Science University Cancer Institute researchers. (2004-06-06)

Annals of Internal Medicine, tip sheet, June 1, 2004
In the June issue of the Annals of Internal Medicine, titles include (2004-05-31)

OTC statins: A bad decision for public health
This week's editorial raises concerns over the recent decision by the UK government to make the cholesterol-lowering drug simvastatin available over the counter (OTC) from July this year for people at moderate risk of cardiovascular disease. (2004-05-20)

Statins show early promise for treating multiple sclerosis
Results of a preliminary study in this week's issue of The Lancet suggest that statins (cholesterol-lowering drugs) could have potential in the treatment of multiple sclerosis (MS). (2004-05-13)

ESC highlights need for screening and global risk management as statins move over the counter in UK
Today Dr John Reid, the Health Secretary for the United Kingdom (UK), announced the reclassification of statins as 'over the counter' products in the UK, to be available to members of the public directly from pharmacists without the need for a prescription. In light of this development, the European Society of Cardiology (ESC) stresses the importance of viewing statins appropriately within the global risk management environment. (2004-05-12)

ACP guidelines: Many diabetics should be taking statins
All people with type 2 diabetes mellitus and coronary artery disease and all people with diabetes and any other risk for cardiovascular disease should be taking cholesterol-lowering drugs called statins, the American College of Physicians said in new guidelines published in the April 20, 2004, issue of Annals of Internal Medicine. This is the second ACP guideline on aggressive management of risk factors for cardiovascular disease in people with type 2 diabetes. (2004-04-19)

Annals of Internal Medicine, tip sheet, April 20, 2004
Highlights from the Annals of Internal Medicine, April 20, 2004 include: new ACP guidelines that say many diabetics should be taking statins, heavy alcohol use is correlated with rise in colorectal cancer rate, and chaos in health care could spur innovation in general internal medicine. (2004-04-19)

Vanderbilt doctors find citrus soda interacts with cyclosporine, maybe statins
Solving the case identified a new food-and-drug interaction that could be harmful for all transplant patients, and, possibly, people taking a class of anti-cholesterol drugs called statins. (2004-04-15)

Statins and aspirin may protect against severe vision loss in elderly
Cholesterol-busting statins, the largest-selling prescription drugs in the U.S., may protect older people from blindness, a new study shows. Aspirin also appears to provide significant protection, according to the research. (2004-04-12)

Cholesterol-lowering drugs may help stroke patients get well
Patients who are taking statins, the cholesterol-lowering drugs, before they suffer a stroke leave hospital in a better state, according to research published in BMC Medicine this week. As statin use is on the increase, perhaps suffering a stroke may no longer have such serious consequences for many people. (2004-03-22)

Implantable cardiac defibrillator use significantly lowers heart failure mortality
The use of an implantable cardiac defibrillator (ICD) can provide a significant reduction in mortality in heart failure patients, according to a study coordinated by researchers from the Duke Clinical Research Institute. (2004-03-08)

Statins could reduce stroke risk by a third
Statins-drugs that lower LDL cholesterol-substantially reduce the incidence of ischaemic stroke among high-risk individuals, conclude authors of a study in this week's issue of THE LANCET. (2004-03-04)

Jefferson researchers uncover biochemical clues to how cells migrate in embryos
Researchers at Jefferson Medical College are gaining a better understanding of the cues that help guide cells to the right places in developing embryos. They have found that a group of anti-cholesterol drugs interfere with a biochemical pathway vital to the migration of germ cells in embryonic zebrafish. Germ cells are stem cells that become either sperm or egg cells. A better understanding of cell migration might lead to insights into disease processes, including cancer. (2004-02-16)

Cheap four-drug combo saves heart patients' lives
An inexpensive cocktail of four tiny pills can make a big difference in heart patients' death risk, a new study finds. And the life-saving effect of the four-drug regimen is bigger than the sum of its parts, but more needs to be done to make sure patients get all the drugs that can help them. (2004-02-16)

Patients should be allowed to pay for statins
GPs should be able to offer private prescriptions for cholesterol lowering drugs (statins) to patients below 3% risk of heart disease, argue researchers in this week's BMJ. (2004-02-12)

Cholesterol drugs may lower risk for mental impairment after stroke
High cholesterol may increase the risk of stroke, but cholesterol-lowering drugs might reduce the risk of impaired brain function after a stroke, according to a study presented today at the American Stroke Association's 29th International Stroke Conference. (2004-02-06)

For leg-bypass patients, drugs can save lives and limbs, but many patients go without them
The same drugs that help millions of heart patients can also aid people who have painful blockages in the blood vessels of their legs, new research shows. Statins and ACE inhibitors can save those patients' lives, or their limbs, if they take the medications before having a leg bypass operation, the study finds. But only about half of patients are getting them. (2004-01-27)

Studies on statin use and fracture risk show mixed results
A review of previous studies suggests a possible benefit of statin drugs for reducing the risk of bone fracture in older women, although further research is needed to examine this question, according to an article in the January 26 issue of The Archives of Internal Medicine, one of the JAMA/Archives journals. (2004-01-26)

Northwestern receives $10 million for cancer prevention trials
Northwestern University has been named one of six leading research institutions to conduct early-phase cancer prevention clinical trials. Of the total $42 million award from National Cancer Institute, Northwestern will receive $10 million. (2003-12-10)

Patients stop meds when benefit changes
Large increases in co-payments in tiered prescription drug plans increase the likelihood that patients will choose not to pay them and to stop taking prescribed drugs, including needed medications for chronic illnesses such as heart disease and acid reflux, according to a study in the New England Journal of Medicine. (2003-12-03)

You're my wife?
Two different research teams in America have documented memory problems that might be associated with patients taking statins, the cholesterol-lowering drugs. In some cases patients' amnesia returned when they resumed taking statins, hinting at a causal link between drug and side effect. (2003-12-03)

Aspirin is most cost effective way to prevent heart disease
Aspirin and blood pressure lowering drugs can prevent heart disease at a fraction of the cost of cholesterol lowering drugs (statins) and clopidogrel (an anti-clotting drug), finds a study in this week's BMJ. (2003-11-27)

Use of statins may prevent breast cancer, say University of Pittsburgh researchers
Cholesterol-lowering medications may help to prevent breast cancer in older women, according to study findings published by University of Pittsburgh researchers in the October issue of the Journal of Women's Health. (2003-10-16)

UT Southwestern faculty members receive American Heart Association's Distinguished Scientist honor
Three scientists at UT Southwestern Medical Center at Dallas are to receive the American Heart Association's newly created Distinguished Scientist title, the highest designation of membership given by the organization. (2003-09-26)

New study aims to prevent heart disease in pediatric lupus patients
Researchers from Duke University Medical Center will study the use of cholesterol-lowering drugs to prevent heart disease in pediatric patients with lupus erythematosus. Atherosclerosis, or hardening of the arteries caused by fat buildup, is a complication of increasing concern to physicians treating children with lupus. Atherosclerosis puts young lupus patients at high risk for cardiac problems including heart attack or stroke. (2003-09-05)

Cholesterol drug increases pain-free walking distance
A cholesterol-lowering drug has the added benefit of improving walking ability in people with peripheral artery disease which causes frequent leg pain, according to a report in today's rapid access issue of Circulation: Journal of the American Heart Association. (2003-09-01)

Cholesterol drug helps heart failure patients without high cholesterol
People with heart failure and normal cholesterol may benefit from cholesterol-lowering drugs called statins, researchers report in today's rapid access issue of Circulation: Journal of the American Heart Association. (2003-07-28)

Annals of Internal Medicine, tip sheet, July 15, 2003
These four articles will be included in the July 15th edition of the Annals of Internal Medicine: Alternating HIV drugs reduced drug failure; Cause of sore throat should be determined before antibiotics are given; Large study shows that statins, popular cholesterol-lowering drugs, do not protect women from fractures and bone loss; and Blood pressure drug protected people with diabetes and normal blood pressure from kidney damage. (2003-07-14)

Green, black tea extracts found to lower cholesterol
Green tea has been associated with lower cholesterol. This study shows in a human randomized, double-blind, placebo controlled trial that a green-tea extract lowered cholesterol by 16 percent. (2003-06-23)

Study finds statins would cut heart attacks and strokes by a third in people with diabetes
Study finds statins would cut heart and strokes by a third in people with diabetes and doctors should routinely consider giving cholesterol-lowering statins to anyone with diabetes who has a substantial risk of a heart attack or a stroke, according to research to be published (Saturday 14 June) in The Lancet medical journal. (2003-06-12)

Statins should be routine therapy for people with diabetes
The risk of cardiovascular disease for people with diabetes could be substantially reduced with the routine use of statins, conclude authors of a study in this week's issue of The Lancet. (2003-06-12)

Lifestyle changes, statins reduce calcium in heart arteries
Lifestyle modification and statin therapy can slow or even reduce calcium deposits in the coronary arteries of patients without symptoms but at risk for coronary artery disease who still have no symptoms. (2003-06-08)

Statins benefit for kidney-transplant patients
Authors of a study published on The Lancet's website today ((2003-06-02)

Calcification process in aortic valves is responsible for blockages
Bone-like cells similar to the cells found in the skeleton calcify in the heart's aortic valve and are responsible for the blockages that lead to the need for open-heart surgery to replace the aortic valve for tens of thousands of Americans, according to researchers at Northwestern Memorial Hospital and Northwestern University. (2003-05-05)

New cholesterol drug paired with statin lowers cholesterol
Combining a new drug that impairs cholesterol absorption in the gut with a drug that impedes cholesterol production in the liver may deliver a one-two punch to lower bad cholesterol, researchers report in today's rapid access issue of Circulation: Journal of the American Heart Association. (2003-04-28)

American Thoraic Society Journal news tips for May 2003 (first issue)
Included in this issue are studies indicating that menopausal women with daytime sleepiness should be evaluated, statin use is very beneficial to lung transplant patients, and more. (2003-04-25)

Cholesterol-lowering drugs shown to decrease predictor of Alzheimer's disease
Cholesterol-lowering medications known as statins also play an important role in reducing levels of a strong predictor of Alzheimer's disease, according to a new study from UT Southwestern Medical Center at Dallas researchers. (2003-04-21)

Science highlights of AAN Annual Meeting in Honolulu March 29 - April 5
Progress in the understanding of multiple sclerosis, the treatment of epilepsy, the progression of Alzheimer's disease, the prevention of stroke, and even the neuroscience of golf were among the highlights of more than 1,300 scientific studies presented at the 55th Annual Meeting of the American Academy of Neurology, held in Honolulu, Hawaii, March 29 - April 5, 2003. (2003-04-14)

A cholesterol-controlling drug could strike a blow against insulin resistance
Type-2 diabetes is now an epidemic. Simvastatin could be key for prevention against this deadly disease. (2003-04-09)

Drug used to treat cholesterol prevents growth of breast cancer cells in lab
Statin drugs used to lower cholesterol may also help prevent development of breast cancer, say researchers who studied the drugs in laboratory cell cultures. (2003-04-07)

Page 24 of 25 | 1000 Results
   First   Previous   Next      Last is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to